ScreenerHero

DB Decibel Cannabis Company Inc.

TSXV · CA · Healthcare · Drug Manufacturers - Specialty & Generic · decibelcc.com
1.690CAD0.00%Mkt Cap: 710.20M $P/E: —

Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada. It is also involved in the extraction, processing, and manuf…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap710.20M USD
Enterprise Value82.03M USD
Revenue (TTM)92.55M USD
Gross Profit30.17M USD
Net Income (TTM)-2.13M USD
Revenue/Share3.30 CAD
Last Price1.690 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)89.04
PEG—
EV/EBITDA10.56
EV/Revenue0.89
P/S7.67
P/B1.01
EPS (TTM)-0.15
EPS (Forward)0.02
52W Range
1.35038% of range2.250
52W High2.250 CAD
52W Low1.350 CAD
Profitability
Gross Margin36.75%
Oper. Margin15.97%
EBITDA Margin8.40%
Profit Margin-2.59%
ROE-4.69%
ROA-2.06%
Growth
Revenue Growth19.30%
Earnings Growth154.00%
Cash Flow & Leverage
Operating CF5.43M USD
CapEx (TTM)1.44M USD
FCF Margin-6.76%
FCF Yield-0.88%
Net Debt34.68M USD
Net Debt/EBITDA4.46
Balance Sheet
Debt/Equity0.71
Current Ratio2.44
Quick Ratio1.42
Book Value/Sh1.68 CAD
Cash/Share0.26 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 9, 2019
Splits
Last Split1:15
Split DateSep 1, 2026
Analyst Consensus
Rating—
Target (Mean)4.000 CAD
Upside (mean)+136.7%
Target Range3.750 CAD – 4.500 CAD
3.750+136.7% to mean4.500
# Analysts3
Ownership
Shares Out.577.04M
Float36.18M
Insiders4.13%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short1.63K
Short (prev mo.)7.90K
Technical
SMA 501.686 (+0.2%)
SMA 2001.707 (-1.0%)
Beta0.53
S&P 52W Chg14.58%
Avg Vol (30d)25.96K
Avg Vol (10d)27.26K
Technical Indicators
RSI (14)53.6
MACD-0.0209
MACD Signal-0.0298
MACD Hist.+0.0089
BB Upper1.815 CAD
BB Middle1.648 CAD
BB Lower1.481 CAD
BB Width20.21%
ATR (14)0.0968 CAD
Vol Ratio (20d)0.96x